Dementia - Treatment;Demenz - Therapie

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 28-29, 2003, Pages 1544-1546

  Stoppe, G ^a   Stiens, G ^a   Staedt, J ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; RIVASTIGMINE; TACRINE;

BRAIN REGION; DEMENTIA; GERMANY; HUMAN; PRACTICE GUIDELINE; REVIEW;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COMBINED MODALITY THERAPY; DEMENTIA; DEMENTIA, VASCULAR; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NOOTROPIC AGENTS; PATIENT EDUCATION; PSYCHOTROPIC DRUGS;

EID: 0038781316     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40382     Document Type: Review

References (9)

1. Acton GJ, Winter MA. Interventions for family members caring for an elder with dementia. Annu Rev Nurs Res 2002; 20: 149-179
2. Arendt T. Das Syndrom der partiellen cholinergen Deafferentierung des kortikalen Mantels - ein Konzept zur Beschreibung des brain-behaviour-relationships bei dementiellen Erkrankungen. Fortschr Neurol Psychiatr 1991; 59: 81-91
3. Areosa SA, Sherriff F. Memantine for dementia. Cochrane Database Syst Rev 2003; 1: CD003154
4. Arzneimittelkommission der deutschen Ärzteschaft, Hrsg. Demenz. Arzneiverordnung in der Praxis. Therapieempfehlungen der Arzneimittelkommission der Deutschen Ärzteschaft. 2001; 2. Auflage
5. Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review. Int J Technol Assess Health Care 2002; 18: 497-507
6. Dodel RC, Hampel H, Du Y. Immunotherapy for Alzheimer's disease. Lancet Neurology 2003; 2: 215-220
7. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. J Am Med Assoc 1996; 276: 1725-1731
8. Stoppe G, Staedt J. Psychopharmakotherapie von Verhaltensstörungen bei Demenzkranken. Z Gerontol Geriat 1999; 32: 153-158
9. Wimo A, Winblad B, Engedal K et al. An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003; 15: 44-54